Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Adial Pharmaceuticals Inc
ADIL
Healthcare
Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. The Company’s drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder (AUD). AD04 is used for the treatment of AUD in subjects with certain target...
genotypes, which were identified using its companion diagnostic genetic test. AD04 is a genetically targeted, serotonin-3 receptor antagonist, a therapeutic agent for the treatment of AUD. The Company’s AD04 also has the potential to treat other addictive disorders such as opioid use disorder, gambling, and obesity. The Company is also developing adenosine analogs for the treatment of pain and other disorders.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ADIL)
New Post
View:
Posts & Comments
Threaded Posts
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Apr 10, 2024 11:57am
RE:RE:ADIL...early a.m runner on watch after NR
Now at $1.86....Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Apr 10, 2024 11:19am
RE:ADIL...early a.m runner on watch after NR
Now at $1.91
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(82)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 10, 2024 10:45am
Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is One of Wednesda
News; $ADIL Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is One of Wednesday Morning's Most Active StocksAdial Pharmaceuticals, Inc. (NASDAQ: ADIL) is one today's most active stocks by volume. So
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 10, 2024 9:37am
ADIL...early a.m runner on watch after NR
Don't get married to this....JMHO Already ran weeks ago ; ) Currently at $2.49
(82)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 28, 2024 2:45pm
S&P 500 Edges Lower; ADT Posts Upbeat Earnings | Benzinga
News; $ADIL S&P 500 Edges Lower; ADT Posts Upbeat Earnings | BenzingaU.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday.The Dow
...more
(82)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 28, 2024 1:45pm
Why is (NASDAQ:VTVT) up more than 100%?
Breaking News: $ADIL Why is (NASDAQ:VTVT) up more than 100%?2024-02-28 13:40:18 ET February 28, 2024, Denver Col, 247marketnews.com Low float stocks continue to grant investors huge wins. Shares of
...more
(82)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 28, 2024 10:15am
Adial Pharmaceuticals Awarded New Patent from the United Sta
News; $ADIL Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office | BenzingaCHARLOTTESVILLE, Va., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth